Stammdaten
BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.
Unternehmen & Branche
| Name | BioNexus Gene Lab Corp |
|---|---|
| Ticker | BGLC |
| CIK | 0001737523 |
| Sektor | Healthcare |
| Industrie | Medical - Diagnostics & Research |
Wertpapier & Kennzahlen
| CUSIP | 090628207 |
|---|---|
| ISIN | US0906282076 |
| Typ | COM NEW |
| Marktkapitalisierung | 3,9 Mio. USD |
| Beta | 2,31 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 7,424,911 | -2,984,607 | 9,252,784 | 8,614,928 | |
| 2025-09-30 | 10-Q | 2,543,823 | -708,991 | -0.40 | 7,621,228 | 6,816,262 |
| 2025-06-30 | 10-Q | 2,260,253 | -616,172 | -0.34 | 9,421,205 | 7,522,037 |
| 2025-03-31 | 10-Q | 2,137,075 | -623,327 | -0.04 | 9,479,939 | 7,771,636 |
| 2024-12-31 | 10-K | 9,510,646 | -1,598,342 | -0.09 | 10,433,848 | 8,322,804 |
| 2024-09-30 | 10-Q | 2,630,376 | -1,345,370 | -0.75 | 10,995,055 | 9,388,173 |
| 2024-06-30 | 10-Q | 1,974,564 | 199,104 | 0.11 | 11,139,727 | 9,545,754 |
| 2024-03-31 | 10-Q | 2,381,851 | -103,757 | -0.01 | 11,161,483 | 9,344,187 |
| 2023-12-31 | 10-K | 9,770,806 | -2,629,043 | -0.17 | 11,399,793 | 9,657,852 |
| 2023-09-30 | 10-Q | 2,553,686 | -2,609,189 | 9,316,088 | ||
| 2023-06-30 | 10-Q | 2,566,848 | -259,251 | 7,898,940 | 5,592,139 | |
| 2023-03-31 | 10-Q | 2,377,205 | -69,066 | 8,186,641 | 6,185,281 | |
| 2022-12-31 | 10-K | 10,928,707 | -355,966 | 8,740,162 | 6,665,013 | |
| 2022-09-30 | 10-Q | 2,575,086 | -77,401 | 7,798,236 | 6,423,654 | |
| 2022-06-30 | 10-Q | 2,485,101 | -138,662 | 8,368,713 | 6,821,647 | |
| 2022-03-31 | 10-Q | 3,028,945 | 17,066 | 9,175,422 | 7,128,069 | |
| 2021-12-31 | 10-K | 13,362,567 | 751,571 | 9,574,390 | 7,179,779 | |
| 2021-09-30 | 10-Q | 3,575,966 | 295,322 | 9,765,004 | 7,051,606 | |
| 2021-06-30 | 10-Q | 3,092,171 | 28,262 | 9,448,123 | 6,813,224 | |
| 2021-03-31 | 10-Q | 3,449,159 | 338,744 | 9,898,531 | 6,792,430 |
Fondsaktivität (Vorquartalsvergleich)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| DRW Securities, LLC | 47,830 | 0 | 47,830 | 188,928 | Neu | +100,0% |
Insider-Transaktionen (12 Monate)
Top-Fondshalter
Hinweis: Keine aktuelleren Daten zu dieser Aktie verfuegbar. Stand der gezeigten 13F-Holdings: 31.12.2025. Letztes global veroeffentlichtes 13F-Quartal: 31.03.2026.
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| DRW Securities, LLC | 47,830 | 188,928 | 100.00 |